Navigation Links
Results From Investigator-Sponsored Trials Presented at SSIEM Conference
Date:9/1/2010

NOVATO, Calif., Sept. 1 /PRNewswire-FirstCall/ -- BioMarin Pharmaceutical Inc. (Nasdaq: BMRN) announced today that results from investigator-sponsored studies on Kuvan (sapropterin dihydrochloride) are being presented at the 2010 Annual Symposium of the Society for The Study of Inborn Errors of Metabolism (SSIEM), August 31st-September 3rd in Istanbul, Turkey. Investigators reported that PKU patients taking Kuvan showed improvements in brain functioning, mood and behaviors.

"While these investigator-sponsored studies were conducted in a small number of subjects, the results indicate benefits beyond lowering blood Phe levels, and we hope to document similar neurocognitive improvements in subjects with PKU in our recently initiated Phase 3b Kuvan outcomes study," said Dr. Hank Fuchs, Chief Medical Officer of BioMarin.  "If successful, the data will be submitted in support of a label amendment."

Highlights of Investigator-Sponsored Studies:Neurocognitive findings in individuals with Phenylketonuria and treatment with sapropterin dihydrochloride (BH4) (White, et al; Washington University, St. Louis): Baseline findings indicate that executive performance is worse for subjects with PKU as compared to non-PKU subjects across a range of executive functions such as inhibitory control, strategic processing and working memory. The results of this exploratory study suggest improvements in executive abilities following treatment with sapropterin.

Brain function in individuals with PKU treated with Kuvan: Evidence from functional magnetic resonance imaging (Christ, et al; University of Missouri-Columbia, USA): At baseline, irregularities in neural activation were observed in subjects with PKU in the prefrontal cortex (PFC) and other brain regions as compared to subjects without PKU. At four weeks, two early-treated PKU participants responded to Kuvan with
'/>"/>

SOURCE BioMarin Pharmaceutical Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. Proprietary Zinc/Phytase Formulation Improved Botulinum Toxin A Results
2. Accuray Announces Results for Fourth Quarter and Fiscal Year 2010
3. CORDIS Announces Results of Ten-Year CYPHER(R) Sirolimus-Eluting Coronary Stent Follow-Up
4. Unilife Corporation Announces Preliminary Financial Results for Fourth Quarter and Fiscal Year 2010
5. Cyberonics Reports Strong Fiscal 2011 First Quarter Results
6. Preliminary Research Results Suggest up to 70% Reduction in Dose for Positron Emission Mammography Imaging
7. Topline Results From Phase 3 Trial of Sunitinib With Erlotinib in Advanced Non-Small Cell Lung Cancer (NSCLC)
8. MedClean Technologies Announces Second Quarter Results
9. Kensey Nash Reports Fourth Quarter and Full Fiscal Year 2010 Financial Results
10. Huifeng Bio-Pharmaceutical Reported Second Quarter 2010 Financial Results and Reaffirms its 2010 Guidance
11. China Yongxin Pharmaceuticals Reports Second Quarter 2010 Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/18/2013)... DENVER , June 18, 2013  Healthgrades, ... evaluate, compare and connect with physicians and hospitals, ... 2013: "Lean in" When Making Healthcare Decisions to ... the best performing hospitals for maternity care, gynecologic ... the treatment of women across 15 of the ...
(Date:6/18/2013)... RIDGE, N.J. , June 18, 2013  Pro ... Adrian Peterson and professional family expert Jo ... partnering with Mylan Specialty L.P., the fully integrated specialty ... ), to raise awareness of this significant health problem. ... the U.S. Food and Drug Administration (FDA) approval of ...
(Date:6/17/2013)... 17, 2013 Vanda Pharmaceuticals Inc. (Vanda) ... today at ENDO 2013, the Endocrine Society,s 95 ... entrain (synchronize) both melatonin and cortisol rhythms. This ... master body clock and address the circadian desynchrony ... SET (Safety and Efficacy of Tasimelteon) and RESET ...
Breaking Medicine Technology:Healthgrades Recognizes Top Hospitals in Treatment of Maternity Care, Gynecologic Surgery and Women's Health 2Healthgrades Recognizes Top Hospitals in Treatment of Maternity Care, Gynecologic Surgery and Women's Health 3Healthgrades Recognizes Top Hospitals in Treatment of Maternity Care, Gynecologic Surgery and Women's Health 4Mylan Specialty L.P. Joins Forces with Adrian Peterson and Jo Frost to Launch Anaphylaxis Preparedness Campaign 2Mylan Specialty L.P. Joins Forces with Adrian Peterson and Jo Frost to Launch Anaphylaxis Preparedness Campaign 3Mylan Specialty L.P. Joins Forces with Adrian Peterson and Jo Frost to Launch Anaphylaxis Preparedness Campaign 4Mylan Specialty L.P. Joins Forces with Adrian Peterson and Jo Frost to Launch Anaphylaxis Preparedness Campaign 5Mylan Specialty L.P. Joins Forces with Adrian Peterson and Jo Frost to Launch Anaphylaxis Preparedness Campaign 6Mylan Specialty L.P. Joins Forces with Adrian Peterson and Jo Frost to Launch Anaphylaxis Preparedness Campaign 7Mylan Specialty L.P. Joins Forces with Adrian Peterson and Jo Frost to Launch Anaphylaxis Preparedness Campaign 8Vanda Presents Data From Phase III Studies that Demonstrate Tasimelteon Restores Daily Cortisol Rhythm In Blind Patients With Non-24-Hour Disorder 2Vanda Presents Data From Phase III Studies that Demonstrate Tasimelteon Restores Daily Cortisol Rhythm In Blind Patients With Non-24-Hour Disorder 3Vanda Presents Data From Phase III Studies that Demonstrate Tasimelteon Restores Daily Cortisol Rhythm In Blind Patients With Non-24-Hour Disorder 4
... 2007 - Cytogen,Corporation (NASDAQ: CYTO) today reported ... 2007 Annual Meeting of the American,Association for ... Angeles,California April 14-18, 2007. The AACR abstracts ... approaches to drug,discovery and development embodied in ...
... DIEGO, March 29, 2007 /PRNewswire-FirstCall/ -- ... and,development company focused on commercializing proprietary ... and infectious diseases,announced today that results ... combination with intravenous 5-fluorouracil (5-FU),and capecitabine ...
Cached Medicine Technology:Preclinical Data on Cytogen's Technology to be Reported at the AACR,Annual Meeting 2Preclinical Data on Cytogen's Technology to be Reported at the AACR,Annual Meeting 3Preclinical Data on Cytogen's Technology to be Reported at the AACR,Annual Meeting 4ADVENTRX to Present CoFactor Multiagent Therapy Data at AACR Annual,Meeting 2ADVENTRX to Present CoFactor Multiagent Therapy Data at AACR Annual,Meeting 3
(Date:6/18/2013)... Alto, CA (PRWEB) June 18, 2013 Palo ... be one of America's greenest cities with its recent major ... Council authorized three major solar electric power purchase agreements ... to 182,500 megawatt-hours (MWh) of solar photovoltaic electric power per ... the City’s electric needs. That’s enough power to supply ...
(Date:6/18/2013)... June 18, 2013 Internationally acclaimed ... new website, thebestbreast.com, showcasing his unique approach to ... information about his surgical method and highlights the ... on his website, Dr. Tebbetts compares his breast ... methods, Dr. Tebbetts’ method does not necessitate the ...
(Date:6/18/2013)... Researchers have discovered and mapped the signaling network between ... broken, could cut off cancer cell growth at its ... The University of Texas MD Anderson Cancer Center reported ... well-known cancer drug target, and MCM7, a protein vital ... June issue of Cancer Cell . , "MCM7 ...
(Date:6/18/2013)... June 18, 2013 myCNAjobs announces the ... free downloads, articles, and tips to the Caregiver Resources ... care for the 10,000+ retiring baby boomers each day, ... caregiver job resources has never been greater. ... job community, recently launched the first-ever free resource ...
(Date:6/18/2013)... Park City, UT (PRWEB) June 18, 2013 ... employees on Health Reimbursement Accounts . Zane Benefits, ... sponsored health benefits, is the leader in defined ... , According to Zane Benefits’ website, employees of a ... Account (HRA) may have questions about how Health Reimbursement ...
Breaking Medicine News(10 mins):Health News:Palo Alto Seals the Deal on Major Solar Electric Investments 2Health News:Palo Alto Seals the Deal on Major Solar Electric Investments 3Health News:Internationally Acclaimed Breast Augmentation Expert Announces the Launch of His New Website 2Health News:Scientists catch EGFR passing a crucial message to cancer-promoting protein 2Health News:myCNAjobs Adds New Resources to Growing Caregiver Career Center 2Health News:Zane Benefits Publishes New Information on Health Reimbursement Accounts 2
... personal music players , , SATURDAY, Feb. 9 (HealthDay News) -- ... American youngsters have noise-induced hearing loss, something that,s entirely preventable, ... launched a public education campaign, called Turn it to the ... it can be prevented simply by turning down the volume ...
... (Nasdaq: AHPI ) reported today that its net income ... from $293,000 last year,or 4 cents per share, to about ... For the first half of the 2008 fiscal year ending ... last year, or six cents,per share, to about $93,500, or ...
... (Nasdaq:,EVVV), a global endovascular device company, today announced the,resignation ... Scientist and,from the company,s board of directors effective February ... people have shaped the treatment of,cardiovascular disease as much ... for improving the lives of patients worldwide," said,Jim Corbett, ...
... Mesa Laboratories,Inc. (Nasdaq: MLAB ) today ... regular quarterly cash dividend of ten cents per ... to shareholders of record at the close of,business ... acquires, manufactures and markets,electronic instruments for industrial, pharmaceutical ...
... profit margin increases; net loss ... remains stable - ... noted), BELLEVILLE, ON, Feb. 8 /PRNewswire-FirstCall/ - Bioniche Life Sciences,Inc. (TSX: ... second,quarter of its 2008 fiscal year, ending December 31, 2007., "The ...
... the Status Quo to Advance,Health Care Reform, ... the,Robert Wood Johnson Foundation,s State Coverage Initiatives program, ... outlines 2007 efforts to,expand health insurance coverage and ... the state level. While many states made progress, ...
Cached Medicine News:Health News:Campaign Targets Noise-Induced Hearing Loss in Kids 2Health News:Allied Healthcare's Net Suffers on Flat Sales, Performance Issues 2Health News:Allied Healthcare's Net Suffers on Flat Sales, Performance Issues 3Health News:Allied Healthcare's Net Suffers on Flat Sales, Performance Issues 4Health News:Allied Healthcare's Net Suffers on Flat Sales, Performance Issues 5Health News:Bioniche Reports Fiscal 2008 Second Quarter 2Health News:Bioniche Reports Fiscal 2008 Second Quarter 3Health News:Bioniche Reports Fiscal 2008 Second Quarter 4Health News:Bioniche Reports Fiscal 2008 Second Quarter 5Health News:Bioniche Reports Fiscal 2008 Second Quarter 6Health News:Bioniche Reports Fiscal 2008 Second Quarter 7Health News:Bioniche Reports Fiscal 2008 Second Quarter 8Health News:Bioniche Reports Fiscal 2008 Second Quarter 9Health News:Bioniche Reports Fiscal 2008 Second Quarter 10Health News:Bioniche Reports Fiscal 2008 Second Quarter 11Health News:Bioniche Reports Fiscal 2008 Second Quarter 12Health News:Bioniche Reports Fiscal 2008 Second Quarter 13Health News:Bioniche Reports Fiscal 2008 Second Quarter 14Health News:Report Lists Key Policy Questions Facing State, National Health Reform 2Health News:Report Lists Key Policy Questions Facing State, National Health Reform 3Health News:Report Lists Key Policy Questions Facing State, National Health Reform 4
... Be Set To Any Degree Interval For Marking ... Outer Diameter Opposing Radials Accommodate All Astigmatic Incisions., ... For AKs, LRIs Or Peripheral Corneal Incisions At ... Paired AKs, LRIs Or Peripheral Corneal Incisions 360 ...
... Unique Reversible Speculums Designed To ... By Flipping The Speculums Over, Allowing ... Palpebral Fissures To The Widest Possible ... Operation, Providing Unobstructed Around-The-Clock Access To ...
... The Forceps Are Available In Two Models: ... Are Compressed, The Jaws Close. The Other ... The Handles Are Compressed The Jaws Open., ,The ... To Be Inserted Through A 1.1mm Incision. These ...
... Allows Use Through A 1-Millimeter Incision.,Special ... Approach To The Incision.,Cystotome Tips Are ... Initiate And Complete A Circular Tear.,Titanium ... Improved Ergonomic Feel. Ideal For Bi-Manual ...
Medicine Products: